451 lines
33 KiB
HTML
451 lines
33 KiB
HTML
<!DOCTYPE html>
|
||
<html lang="zh-CN" data-theme="night">
|
||
<head>
|
||
<meta charset="UTF-8">
|
||
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
||
<title>AI医疗 | 深度概念解析</title>
|
||
<link href="https://cdn.jsdelivr.net/npm/daisyui@4.10.1/dist/full.min.css" rel="stylesheet" type="text/css" />
|
||
<script src="https://cdn.tailwindcss.com"></script>
|
||
<script defer src="https://cdn.jsdelivr.net/npm/alpinejs@3.x.x/dist/cdn.min.js"></script>
|
||
<script src="https://cdn.jsdelivr.net/npm/echarts@5.5.0/dist/echarts.min.js"></script>
|
||
<style>
|
||
@import url('https://fonts.googleapis.com/css2?family=Lexend:wght@300;400;500;600;700&display=swap');
|
||
body {
|
||
font-family: 'Lexend', sans-serif;
|
||
background-color: #020010;
|
||
background-image:
|
||
radial-gradient(at 20% 25%, hsla(212, 80%, 30%, 0.3) 0px, transparent 50%),
|
||
radial-gradient(at 80% 20%, hsla(280, 80%, 40%, 0.25) 0px, transparent 50%),
|
||
radial-gradient(at 50% 80%, hsla(190, 80%, 50%, 0.2) 0px, transparent 50%);
|
||
color: #e0e0e0;
|
||
}
|
||
.glass-card {
|
||
background: rgba(12, 10, 29, 0.5);
|
||
-webkit-backdrop-filter: blur(20px);
|
||
backdrop-filter: blur(20px);
|
||
border: 1px solid rgba(255, 255, 255, 0.1);
|
||
transition: all 0.3s ease;
|
||
}
|
||
.glass-card:hover {
|
||
border-color: rgba(100, 200, 255, 0.3);
|
||
box-shadow: 0 0 30px rgba(100, 200, 255, 0.1);
|
||
}
|
||
.glow-text {
|
||
text-shadow: 0 0 8px rgba(173, 216, 230, 0.6);
|
||
}
|
||
.bento-grid {
|
||
display: grid;
|
||
grid-template-columns: repeat(12, 1fr);
|
||
gap: 1.5rem;
|
||
}
|
||
.grid-span-12 { grid-column: span 12; }
|
||
.grid-span-8 { grid-column: span 12; }
|
||
.grid-span-6 { grid-column: span 12; }
|
||
.grid-span-4 { grid-column: span 12; }
|
||
@media (min-width: 1024px) {
|
||
.grid-span-8 { grid-column: span 8; }
|
||
.grid-span-6 { grid-column: span 6; }
|
||
.grid-span-4 { grid-column: span 4; }
|
||
}
|
||
.section-title {
|
||
font-size: 1.5rem;
|
||
font-weight: 600;
|
||
color: #c0d8ff;
|
||
border-left: 3px solid #63a3ff;
|
||
padding-left: 1rem;
|
||
margin-bottom: 1.5rem;
|
||
}
|
||
.timeline {
|
||
position: relative;
|
||
padding-left: 2rem;
|
||
border-left: 2px solid rgba(255, 255, 255, 0.15);
|
||
}
|
||
.timeline-item {
|
||
position: relative;
|
||
margin-bottom: 2rem;
|
||
}
|
||
.timeline-item::before {
|
||
content: '';
|
||
position: absolute;
|
||
left: -2.5rem;
|
||
top: 0;
|
||
width: 1rem;
|
||
height: 1rem;
|
||
border-radius: 50%;
|
||
background-color: #63a3ff;
|
||
border: 3px solid #1a1a3d;
|
||
box-shadow: 0 0 10px rgba(99, 163, 255, 0.5);
|
||
}
|
||
.tab-lifted {
|
||
background-color: rgba(12, 10, 29, 0.7) !important;
|
||
border-color: rgba(255, 255, 255, 0.1) !important;
|
||
color: #a0a0a0;
|
||
}
|
||
.tab-lifted.tab-active {
|
||
background-color: rgba(26, 26, 61, 0.7) !important;
|
||
color: #e0e0e0;
|
||
border-bottom-color: transparent !important;
|
||
font-weight: 600;
|
||
}
|
||
</style>
|
||
</head>
|
||
<body class="min-h-screen p-4 sm:p-6 md:p-8">
|
||
<div class="max-w-screen-2xl mx-auto">
|
||
<!-- Header -->
|
||
<header class="text-center mb-12">
|
||
<h1 class="text-4xl md:text-5xl font-bold glow-text bg-gradient-to-r from-cyan-300 via-blue-400 to-purple-400 bg-clip-text text-transparent mb-4">
|
||
AI医疗 | 深度概念解析
|
||
</h1>
|
||
<p class="text-sm text-gray-400">
|
||
北京价值前沿科技有限公司 AI投研agent：“价小前投研” 呈现。本报告为AI合成数据，投资需谨慎。
|
||
</p>
|
||
</header>
|
||
|
||
<main class="space-y-6">
|
||
<!-- Core Insight Section -->
|
||
<section class="bento-grid">
|
||
<!-- Core Viewpoint -->
|
||
<div class="grid-span-12 glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">核心观点摘要</h2>
|
||
<p class="text-lg text-gray-300 leading-relaxed">AI医疗正处于从概念炒作向商业化落地过渡的关键“元年”。其核心驱动力已从单纯的算法比拼，转变为<strong class="text-cyan-300">“数据资产+应用场景”的双轮驱动</strong>，政策的强力催化与开源模型的“技术平权”共同加速了这一进程。未来，最大的潜力在于通过AI重构医疗服务的效率与成本结构，而拥有<strong class="text-purple-300">高质量、多模态数据闭环和清晰商业模式</strong>的公司将构筑最深的护城河。</p>
|
||
</div>
|
||
|
||
<!-- Timeline -->
|
||
<div class="grid-span-4 glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">概念发展脉络</h2>
|
||
<div class="timeline">
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-sky-300">2024.04</h3>
|
||
<p class="text-sm text-gray-400">工信部等印发《实施方案》，定调AI赋能医药工业。</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-sky-300">2025.01</h3>
|
||
<p class="text-sm text-gray-400">美股Tempus AI展示“数据飞轮”模式，提供清晰对标。</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-sky-300">2025.02</h3>
|
||
<p class="text-sm text-gray-400">DeepSeek开源低成本大模型，开启“AI平权”时代。</p>
|
||
</div>
|
||
<div class="timeline-item">
|
||
<h3 class="font-semibold text-sky-300">2025.07</h3>
|
||
<p class="text-sm text-gray-400">广东卫健委发布44个应用场景；英伟达H20恢复对华销售；支付宝推医疗Agent。</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- Core Logic -->
|
||
<div class="grid-span-8 glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">核心逻辑与市场认知</h2>
|
||
<div class="space-y-6">
|
||
<div>
|
||
<h3 class="font-semibold text-lg text-sky-300 mb-2">1. 技术范式变革：“AI平权”催生数据为王</h3>
|
||
<p class="text-gray-400">以 <strong class="text-white">DeepSeek开源</strong> 为标志，产业瓶颈从模型能力转向数据价值。竞争焦点变为“谁拥有更优质、独占、多维度的医疗数据，并能与场景更好结合”。拥有数据和渠道优势的传统医疗公司价值凸显。</p>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-lg text-sky-300 mb-2">2. 政策顶层设计：从“鼓励”到“规划应用”</h3>
|
||
<p class="text-gray-400">从工信部方案到广东 <strong class="text-white">44个应用场景案例</strong>，政策导向从宏观鼓励转为具体落地指引，为商业化提供了确定性，并有助于解决初期支付方意愿问题。</p>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-lg text-sky-300 mb-2">3. 商业模式清晰化：海外映射与国内探索</h3>
|
||
<p class="text-gray-400">美股 <strong class="text-white">Tempus AI</strong> 提供了“数据即服务”的价值重估范本。国内虽医保支付是挑战，但<strong class="text-white">效率提升</strong>（诊断效率提升30倍）和<strong class="text-white">服务增值</strong>（患者服务收入占比提升）正成为医院采购的核心动力，形成非医保依赖路径。</p>
|
||
</div>
|
||
<div>
|
||
<h3 class="font-semibold text-lg text-red-400 mb-2">※ 预期差分析</h3>
|
||
<ul class="list-disc list-inside space-y-2 text-gray-400">
|
||
<li><strong class="text-amber-300">大模型幻觉 vs. 经济账：</strong> 市场高估通用大模型，低估了针对场景的<strong class="text-white">轻量化、低成本、高响应</strong>模型优化的价值。</li>
|
||
<li><strong class="text-amber-300">技术酷炫 vs. 商业泥泞：</strong> 市场对<strong class="text-white">数据污染、支付方、责任界定</strong>三大商业化核心挑战预期不足。</li>
|
||
<li><strong class="text-amber-300">AI叙事 vs. 数据生态：</strong> 市场高估简单“接入”大模型的能力，低估了构建如Tempus AI的<strong class="text-white">高质量、多模态、可持续数据生态</strong>的长期壁垒。</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Catalysts & Path -->
|
||
<section class="bento-grid">
|
||
<div class="grid-span-6 glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">关键催化剂</h2>
|
||
<div class="space-y-4">
|
||
<div>
|
||
<h4 class="font-semibold text-blue-300">近期 (3-6个月)</h4>
|
||
<ul class="list-disc list-inside text-gray-400 mt-2 space-y-1">
|
||
<li>标杆项目商业成果披露 (如具体收入数据、付费模式)。</li>
|
||
<li>重量级三类医疗器械AI软件获NMPA批准。</li>
|
||
<li>国家级/区域级AI服务纳入医保支付的试点政策突破。</li>
|
||
<li>科技巨头（华为/阿里）发布具有市场影响力的标准化产品。</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="grid-span-6 glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">未来发展路径</h2>
|
||
<div class="space-y-4">
|
||
<div>
|
||
<h4 class="font-semibold text-blue-300">近期 (1-2年): 单点应用深化</h4>
|
||
<p class="text-gray-400">集中在AI影像、AI+IVD、CDSS等成熟领域，以“降本增效”为核心，商业模式以软件采购、服务订阅为主。</p>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-semibold text-blue-300">中期 (2-5年): 流程融合与多模态整合</h4>
|
||
<p class="text-gray-400">多模态大模型成为主流，AI深度嵌入诊疗全流程。AI制药有望诞生首个自主研发上市新药。</p>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-semibold text-blue-300">远期 (5年以上): 个性化健康管理与生态构建</h4>
|
||
<p class="text-gray-400">C端“AI健康管家”成熟，形成“医+药+险+康养”生态闭环，实现从治疗到预防的模式转变。</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Industry Chain & Players -->
|
||
<section class="glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">产业链与核心公司深度剖析</h2>
|
||
<div class="overflow-x-auto">
|
||
<table class="table table-zebra bg-transparent">
|
||
<thead class="text-base text-cyan-200">
|
||
<tr>
|
||
<th>公司名称</th>
|
||
<th>核心逻辑与优势</th>
|
||
<th>业务进展与数据支撑</th>
|
||
<th>潜在风险</th>
|
||
<th class="text-center">逻辑纯粹度</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody class="text-gray-300">
|
||
<tr>
|
||
<td class="font-bold">联影医疗</td>
|
||
<td>“硬件+AI”生态闭环，通过设备占据入口，AI订阅提升ARPU，技术壁垒高。</td>
|
||
<td>拥有12张三类证、21张二类证。AI技术将MR扫描时间从30分钟缩至几分钟。</td>
|
||
<td>AI订阅服务规模化收入尚需验证，资产较重。</td>
|
||
<td class="text-center"><div class="badge badge-accent">高</div></td>
|
||
</tr>
|
||
<tr>
|
||
<td class="font-bold">讯飞医疗</td>
|
||
<td>“算法+场景”双轮驱动，以星火大模型为核心，基层CDSS垄断优势，B/C端拓展。</td>
|
||
<td>基层CDSS市占率61.5%，AI医疗收入市占率5.9%行业第一，患者服务收入占比提升至41%。</td>
|
||
<td>C端市场竞争激烈，需持续高研发投入。</td>
|
||
<td class="text-center"><div class="badge badge-success">非常高</div></td>
|
||
</tr>
|
||
<tr>
|
||
<td class="font-bold">医渡科技</td>
|
||
<td>“多模态数据平台”，核心资产是55亿+医疗记录和融合分析能力，赋能临床科研。</td>
|
||
<td>服务102家顶级医院，数据规模为行业平均值10倍以上，提供无代码AI Agent工具。</td>
|
||
<td>数据安全合规是生命线，项目制模式规模化复制和盈利能力需观察。</td>
|
||
<td class="text-center"><div class="badge badge-accent">高</div></td>
|
||
</tr>
|
||
<tr>
|
||
<td class="font-bold">润达医疗</td>
|
||
<td>传统IVD龙头成功转型，利用现有医院渠道嫁接AI能力，信息化业务快速增长。</td>
|
||
<td>25H1医疗信息化收入0.94亿元(同比+40.73%)，已为超百家医院提供AI解决方案。</td>
|
||
<td>AI业务在总营收中占比较小，能否持续高增长是关键。</td>
|
||
<td class="text-center"><div class="badge badge-warning">中 (转型)</div></td>
|
||
</tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Supporting Evidence Section -->
|
||
<section class="glass-card rounded-3xl p-6 md:p-8" x-data="{ tab: 'news' }">
|
||
<div role="tablist" class="tabs tabs-lifted mb-6">
|
||
<a role="tab" class="tab tab-lifted" :class="{'tab-active': tab === 'news'}" @click.prevent="tab = 'news'">新闻洞察</a>
|
||
<a role="tab" class="tab tab-lifted" :class="{'tab-active': tab === 'roadshow'}" @click.prevent="tab = 'roadshow'">路演精华</a>
|
||
<a role="tab" class="tab tab-lifted" :class="{'tab-active': tab === 'report'}" @click.prevent="tab = 'report'">研报聚焦</a>
|
||
</div>
|
||
|
||
<div x-show="tab === 'news'">
|
||
<h3 class="text-xl font-semibold mb-4 text-sky-200">市场宏观趋势与观点</h3>
|
||
<div class="grid grid-cols-1 md:grid-cols-2 gap-4">
|
||
<div>
|
||
<ul class="list-disc list-inside space-y-2 text-gray-400">
|
||
<li><strong>市场热情：</strong> 海外资本市场热情高涨，国内受益政策支持，信达证券认为2025年将是AI医疗发展元年。</li>
|
||
<li><strong>核心转变：</strong> 产业发展重点从大模型能力转向<strong class="text-white">数据的AI价值开发与应用场景落地</strong>。</li>
|
||
<li><strong>海外映射：</strong> 美股Tempus AI等公司上涨，先行兑现AI赋能医疗数据价值重估逻辑。</li>
|
||
<li><strong>政策催化：</strong> 工信部、广东卫健委等密集出台政策，华为组建医疗卫生军团，推动行业发展。</li>
|
||
<li><strong>技术平权：</strong> DeepSeek低成本开源大模型，赋能全场景数据价值重估，降低企业AI部署门槛。</li>
|
||
</ul>
|
||
</div>
|
||
<div class="w-full h-64 md:h-full" id="marketSizeChart"></div>
|
||
</div>
|
||
</div>
|
||
|
||
<div x-show="tab === 'roadshow'">
|
||
<h3 class="text-xl font-semibold mb-4 text-sky-200">关键公司战略与技术亮点</h3>
|
||
<ul class="list-disc list-inside space-y-3 text-gray-400">
|
||
<li><strong>联影医疗：</strong> 打造“硬件+AI”闭环，设备销售为入口，AI订阅服务提升ARPU。拥有全球最大规模医疗影像数据集，通过“知识蒸馏”开发<strong class="text-white">轻量化模型</strong>应对临床高并发场景。</li>
|
||
<li><strong>讯飞医疗：</strong> 以“星火大模型”为核心，基层CDSS市占率达<strong class="text-white">61.5%</strong>。B端智慧医院和C端健康管理成为核心增长驱动力。</li>
|
||
<li><strong>Tempus AI (美股对标)：</strong> 核心壁垒是与全美<strong class="text-white">50%医院</strong>建立的双向数据管道和多模态数据集，形成“数据飞轮”效应。FDA认证ECG算法获<strong class="text-white">$128/例</strong>医保编码。</li>
|
||
<li><strong>医渡科技：</strong> 核心技术为“医疗大脑”，累计处理<strong class="text-white">55亿份</strong>授权医疗记录，支持多模态数据融合分析，医生可在30秒内搭建专病AI Agent。</li>
|
||
<li><strong>塞力医疗 & 华为：</strong> 华为提供昇腾算力、盘古大模型，塞力医疗依托临床数据和场景开发垂直应用（如精神疾病、细菌耐药大模型），产品IP归属塞力医疗。</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<div x-show="tab === 'report'">
|
||
<h3 class="text-xl font-semibold mb-4 text-sky-200">核心标的研究报告摘要</h3>
|
||
<ul class="list-disc list-inside space-y-3 text-gray-400">
|
||
<li><strong>联影医疗 (688271.SH):</strong> 增资联影智能，强化AI布局。联影智能是全栈全谱医疗AI公司，拥有12张NMPA三类证，2023年营收2.54亿元，投后估值约<strong class="text-white">100亿元</strong>。</li>
|
||
<li><strong>讯飞医疗 (2506.HK):</strong> 中国医疗AI市场份额<strong class="text-white">5.9%</strong>排名第一。依托星火医疗大模型，在诊断推荐等任务上表现超越GPT-4o。业务覆盖G/B/C三端，智医助理覆盖超7万个基层医疗机构。</li>
|
||
<li><strong>九安医疗 (002432.SZ):</strong> 积极投资AI领域，包括<strong class="text-white">月之暗面</strong>。慢病管理是其最易产生AI助手的领域，后续CGM产品适合叠加AI，打造更有黏性的场景。</li>
|
||
<li><strong>润达医疗 (603108.SH):</strong> AI医疗业务加速落地，25H1医疗信息化收入<strong class="text-white">同比+40.73%</strong>。与华西、齐鲁等合作，在杭州、山东等地落地城市医疗一朵云方案，与美年健康合作AI体检报告解读。</li>
|
||
</ul>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Potential Risks -->
|
||
<section class="glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title text-red-400 border-red-400">潜在风险与挑战</h2>
|
||
<div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
|
||
<div>
|
||
<h4 class="font-semibold text-amber-300">技术风险</h4>
|
||
<ul class="list-disc list-inside text-gray-400 mt-2 space-y-1">
|
||
<li>模型可靠性与“幻觉”问题，在医疗领域后果严重。</li>
|
||
<li>多模态数据（影像、文本、基因）有效融合的技术瓶颈。</li>
|
||
</ul>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-semibold text-amber-300">商业化风险</h4>
|
||
<ul class="list-disc list-inside text-gray-400 mt-2 space-y-1">
|
||
<li>支付方缺位：国内医保控费为主，AI服务付费模式尚不成熟。</li>
|
||
<li>成本与ROI不明确，医院付费意愿和持续性存疑。</li>
|
||
<li>责任界定与伦理问题：医疗事故法律责任划分尚无明确规定。</li>
|
||
</ul>
|
||
</div>
|
||
<div>
|
||
<h4 class="font-semibold text-amber-300">政策与竞争风险</h4>
|
||
<ul class="list-disc list-inside text-gray-400 mt-2 space-y-1">
|
||
<li>数据安全与隐私监管政策收紧风险。</li>
|
||
<li>市场格局分散，大量企业涌入，可能出现价格战，中小企业生存受挤压。</li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<!-- Stock List -->
|
||
<section class="glass-card rounded-3xl p-6 md:p-8">
|
||
<h2 class="section-title">相关概念股梳理</h2>
|
||
<div class="overflow-x-auto">
|
||
<table class="table table-compact w-full bg-transparent">
|
||
<thead class="text-sm text-cyan-200">
|
||
<tr>
|
||
<th>股票名称</th>
|
||
<th>代码</th>
|
||
<th>核心逻辑/关联原因</th>
|
||
<th>分类标签</th>
|
||
</tr>
|
||
</thead>
|
||
<tbody class="text-gray-300">
|
||
<!-- Data will be populated by script -->
|
||
|
||
<tr><td>润达医疗</td><td><a href='https://valuefrontier.cn/company?scode=603108' target='_blank' class='link link-hover text-blue-400'>603108</a></td><td>医学AI智能体“睿兵Agent”由华西医院联合润达医疗、华为、智算云腾(成都)共同研发</td><td>华为AI医疗, 医疗大模型, 智慧医疗</td></tr>
|
||
<tr><td>塞力医疗</td><td><a href='https://valuefrontier.cn/company?scode=603716' target='_blank' class='link link-hover text-blue-400'>603716</a></td><td>与华为武汉研究所合作脑科学大模型、罕见病/危重症等专病大模型、微生物耐药诊疗及预测大模型</td><td>华为AI医疗, 医疗大模型, DEEPSEEK, 智慧医疗</td></tr>
|
||
<tr><td>科大讯飞</td><td><a href='https://valuefrontier.cn/company?scode=002230' target='_blank' class='link link-hover text-blue-400'>002230</a></td><td>华为与讯飞医疗开发智能医疗助手(支持语音病历、智能查房)</td><td>华为AI医疗, 医疗大模型</td></tr>
|
||
<tr><td>美年健康</td><td><a href='https://valuefrontier.cn/company?scode=002044' target='_blank' class='link link-hover text-blue-400'>002044</a></td><td>联合华为云、润达医疗打造的“健康小美”辅助医生进行疾病诊断</td><td>华为AI医疗, 医疗大模型, 智慧医疗</td></tr>
|
||
<tr><td>安必平</td><td><a href='https://valuefrontier.cn/company?scode=688393' target='_blank' class='link link-hover text-blue-400'>688393</a></td><td>基于昇腾AI在病理数据库和算力生态方面,打造整个病理科全科数字化的产品。</td><td>华为AI医疗, 检验/病理, AI检测</td></tr>
|
||
<tr><td>迪安诊断</td><td><a href='https://valuefrontier.cn/company?scode=300244' target='_blank' class='link link-hover text-blue-400'>300244</a></td><td>携手华为云发布迪安医检大模型</td><td>华为AI医疗, 检验/病理, DEEPSEEK, 智慧医疗, AI检测</td></tr>
|
||
<tr><td>金域医学</td><td><a href='https://valuefrontier.cn/company?scode=603882' target='_blank' class='link link-hover text-blue-400'>603882</a></td><td>合作华为推出AI辅助病理诊断，AI辅助宫颈癌筛查模型</td><td>华为AI医疗, 检验/病理, AI医疗其他相关, AI检测</td></tr>
|
||
<tr><td>联影医疗</td><td><a href='https://valuefrontier.cn/company?scode=688271' target='_blank' class='link link-hover text-blue-400'>688271</a></td><td>联影与华为战略签约构建医疗新生态；AI影像设备市占率领先</td><td>华为AI医疗, 影像</td></tr>
|
||
<tr><td>万东医疗</td><td><a href='https://valuefrontier.cn/company?scode=600055' target='_blank' class='link link-hover text-blue-400'>600055</a></td><td>合作华为云影像医疗平台。</td><td>华为AI医疗, 影像, AI检测</td></tr>
|
||
<tr><td>卫宁健康</td><td><a href='https://valuefrontier.cn/company?scode=300253' target='_blank' class='link link-hover text-blue-400'>300253</a></td><td>与华为在AI辅助诊断等医疗信息化领域有合作</td><td>华为AI医疗, 医疗信息化, 智慧医疗</td></tr>
|
||
<tr><td>万达信息</td><td><a href='https://valuefrontier.cn/company?scode=300168' target='_blank' class='link link-hover text-blue-400'>300168</a></td><td>华为金牌合作伙伴，AI赋能DIP医保支付系统市占率领先</td><td>华为AI医疗, 医疗信息化, 智慧医疗</td></tr>
|
||
<tr><td>东软集团</td><td><a href='https://valuefrontier.cn/company?scode=600718' target='_blank' class='link link-hover text-blue-400'>600718</a></td><td>医疗健康信息化领域的全面生态伙伴，基于华为大模型技术，推出了多款“AI+医疗”行业应用</td><td>华为AI医疗, 医疗信息化, 智慧医疗</td></tr>
|
||
<tr><td>创业慧康</td><td><a href='https://valuefrontier.cn/company?scode=300451' target='_blank' class='link link-hover text-blue-400'>300451</a></td><td>华为医疗云核心合作伙伴，AI技术应用于诊疗决策支持</td><td>华为AI医疗, 医疗信息化, 医疗公共事业, 智慧医疗</td></tr>
|
||
<tr><td>阳光诺和</td><td><a href='https://valuefrontier.cn/company?scode=688621' target='_blank' class='link link-hover text-blue-400'>688621</a></td><td>与华为深度合作开发基于华为盘古大模型的AI多肽分子大模型平台</td><td>华为AI医疗, 制药</td></tr>
|
||
<tr><td>华大基因</td><td><a href='https://valuefrontier.cn/company?scode=300676' target='_blank' class='link link-hover text-blue-400'>300676</a></td><td>华为与华大基因在华为云计算大会2015上，签署《基因大数据存储系统联合开发协议》</td><td>华为AI医疗, 基因检测, AI检测</td></tr>
|
||
<tr><td>贝瑞基因</td><td><a href='https://valuefrontier.cn/company?scode=000710' target='_blank' class='link link-hover text-blue-400'>000710</a></td><td>公司与国内数据云的领航者华为云和阿里云结成战略合作伙伴</td><td>华为AI医疗, 基因检测, DEEPSEEK, AI检测</td></tr>
|
||
/*... Additional stock rows ... */
|
||
<tr><td>朗玛信息</td><td><a href='https://valuefrontier.cn/company?scode=300288' target='_blank' class='link link-hover text-blue-400'>300288</a></td><td>AI诊断</td><td>AI医疗其他相关, AI诊断, 智慧医疗</td></tr>
|
||
<tr><td>祥生医疗</td><td><a href='https://valuefrontier.cn/company?scode=688358' target='_blank' class='link link-hover text-blue-400'>688358</a></td><td>AI诊断</td><td>AI医疗其他相关, AI诊断, AI检测</td></tr>
|
||
<tr><td>成都先导</td><td><a href='https://valuefrontier.cn/company?scode=688222' target='_blank' class='link link-hover text-blue-400'>688222</a></td><td>AI制药</td><td>AI医疗其他相关, AI制药</td></tr>
|
||
<tr><td>泓博医药</td><td><a href='https://valuefrontier.cn/company?scode=301230' target='_blank' class='link link-hover text-blue-400'>301230</a></td><td>AI制药</td><td>AI医疗其他相关, AI制药</td></tr>
|
||
<tr><td>九安医疗</td><td><a href='https://valuefrontier.cn/company?scode=002432' target='_blank' class='link link-hover text-blue-400'>002432</a></td><td>AI健康管理</td><td>AI医疗其他相关, AI健康管理</td></tr>
|
||
<tr><td>嘉和美康</td><td><a href='https://valuefrontier.cn/company?scode=688246' target='_blank' class='link link-hover text-blue-400'>688246</a></td><td>医疗信息化</td><td>医疗公共事业, 医疗信息化, 智慧医疗</td></tr>
|
||
<tr><td>久远银海</td><td><a href='https://valuefrontier.cn/company?scode=002777' target='_blank' class='link link-hover text-blue-400'>002777</a></td><td>医保相关</td><td>医疗公共事业, 医保相关, 智慧医疗</td></tr>
|
||
<tr><td>山大地纬</td><td><a href='https://valuefrontier.cn/company?scode=688579' target='_blank' class='link link-hover text-blue-400'>688579</a></td><td>医保相关</td><td>医疗公共事业, 医保相关, 智慧医疗</td></tr>
|
||
<tr><td>思创医惠</td><td><a href='https://valuefrontier.cn/company?scode=300078' target='_blank' class='link link-hover text-blue-400'>300078</a></td><td>SPD/DRG</td><td>医疗公共事业, SPD/DRG, 智慧医疗</td></tr>
|
||
</tbody>
|
||
</table>
|
||
</div>
|
||
</section>
|
||
</main>
|
||
</div>
|
||
|
||
<script>
|
||
document.addEventListener('DOMContentLoaded', function () {
|
||
var chartDom = document.getElementById('marketSizeChart');
|
||
if (chartDom) {
|
||
var myChart = echarts.init(chartDom, 'dark');
|
||
var option;
|
||
|
||
option = {
|
||
backgroundColor: 'transparent',
|
||
title: {
|
||
text: '国内AI医疗应用规模 (亿元)',
|
||
left: 'center',
|
||
textStyle: {
|
||
color: '#ccc'
|
||
}
|
||
},
|
||
tooltip: {
|
||
trigger: 'axis',
|
||
axisPointer: {
|
||
type: 'shadow'
|
||
}
|
||
},
|
||
grid: {
|
||
left: '3%',
|
||
right: '4%',
|
||
bottom: '3%',
|
||
containLabel: true
|
||
},
|
||
xAxis: [
|
||
{
|
||
type: 'category',
|
||
data: ['2023年', '2024年 (预计)'],
|
||
axisTick: {
|
||
alignWithLabel: true
|
||
},
|
||
axisLine: {
|
||
lineStyle: {
|
||
color: 'rgba(255,255,255,0.3)'
|
||
}
|
||
}
|
||
}
|
||
],
|
||
yAxis: [
|
||
{
|
||
type: 'value',
|
||
axisLine: {
|
||
show: true,
|
||
lineStyle: {
|
||
color: 'rgba(255,255,255,0.3)'
|
||
}
|
||
},
|
||
splitLine: {
|
||
lineStyle: {
|
||
color: 'rgba(255,255,255,0.1)'
|
||
}
|
||
}
|
||
}
|
||
],
|
||
series: [
|
||
{
|
||
name: '市场规模',
|
||
type: 'bar',
|
||
barWidth: '60%',
|
||
data: [780.5, 936.6],
|
||
itemStyle: {
|
||
color: new echarts.graphic.LinearGradient(0, 0, 0, 1, [
|
||
{ offset: 0, color: '#2378f7' },
|
||
{ offset: 0.7, color: '#83bff6' },
|
||
{ offset: 1, color: '#188df0' }
|
||
])
|
||
}
|
||
}
|
||
]
|
||
};
|
||
myChart.setOption(option);
|
||
window.addEventListener('resize', myChart.resize);
|
||
}
|
||
});
|
||
</script>
|
||
</body>
|
||
</html> |